Skip to main content
Log in

Poor glycaemic control major driver of healthcare costs in T2DM

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Mata-Cases M, et al. The Association Between Poor Glycemic Control and Health Care Costs in People With Diabetes: A Population-Based Study. Diabetes Care : 6 Feb 2020. Available from: URL: http://doi.org/10.2337/dc19-0573

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Poor glycaemic control major driver of healthcare costs in T2DM. PharmacoEcon Outcomes News 847, 26 (2020). https://doi.org/10.1007/s40274-020-6602-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-6602-2

Navigation